Edward Hodgkin
InvestorManaging Partner of Syncona Investment Management Ltd. at Syncona
About
Edward Hodgkin is a Managing Partner at Syncona Investment Management, with more than 30 years of experience across pharmaceuticals, biotech, and healthcare investing. He has helped found and operationally build Syncona portfolio companies, serving as the first CEO of Autolus Therapeutics and founding CEO of Resolution Therapeutics. Earlier in his career he held leadership roles at Biotica, BrainCells, Tripos, Wyeth-Ayerst, and British Biotech, and holds a degree and DPhil in Chemistry from the University of Oxford.
Invests in
BiotechHealthtech
Investments
Board seats
ALTxAutolus TherapeuticsMosaic TherapeuticsOMass TherapeuticsResolution TherapeuticsSlingshot Therapeutics
Per the firm's website.
